5 months ago
PFE
AnalystsTerence FlynnTerence Flynn's Stock Forecasts
AnalystsTerence Flynn
Sectors:
Analyst Ranking
Top 8%
#330 out of 4426 analysts
Average Return
+13.42%
Win Rate
57%41 out of 72
Risk vs Reward
Poor
Good
Terence Flynn's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Translate Bio IncTBIO1 | +147.91% | $15.07 | $37.36 | 2020-10-05 - 2021-09-14 | Strong Buy |
Blueprint Medicines CorpBPMC | +140.20% | $41.34 | $99.30 | 2017-03-13 - 2018-03-13 | Strong Buy |
Eli Lilly & CoLLY | +90.36% | $314.17 | $598.05 | 2023-03-01 - 2023-12-08 | Strong Buy |
Eli Lilly & CoLLY | +86.49% | $324.57 | $605.28 | 2022-10-12 - 2023-10-11 | Strong Buy |
Eli Lilly & CoLLY | +79.70% | $311.60 | $559.95 | 2022-09-07 - 2023-09-06 | Strong Buy |
Terence Flynn Analyst Color
Get additional color on Terence Flynn's coverage of popular stocks
8 months ago
JNJ
8 months ago
PFE
8 months ago
JNJ
8 months ago
LLY
a year ago
JNJ
a year ago
JNJ
a year ago
PFE
a year ago
MRK
a year ago
JNJ
a year ago
ABBV
2 years ago
LLY
2 years ago
ABBV
2 years ago
RPRX
Terence Flynn's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcus Biosciences IncRCUS | 3 | Strong Buy | $35.00 | +121.94% | Maintains | a month ago |
Arvinas IncARVN | 6 | Hold | $20.00 | -41.45% | Maintains | a month ago |
Crispr Therapeutics AgCRSP | 5 | Strong Sell | $42.00 | -34.92% | Maintains | a month ago |
Intellia Therapeutics IncNTLA | 4 | Strong Buy | $85.00 | +192.90% | Maintains | a month ago |
Royalty Pharma PLCRPRX | 10 | Strong Buy | $57.00 | +99.51% | Maintains | a month ago |
C4 Therapeutics IncCCCC | 4 | Hold | $1.00 | -23.08% | Upgrades | a month ago |
United Therapeutics CorpUTHR | 7 | Strong Buy | $314.00 | +29.94% | Maintains | a month ago |
Pfizer IncPFE | 12 | Hold | $37.00 | +28.56% | Maintains | a month ago |
Amgen IncAMGN | 2 | Hold | $291.00 | +8.13% | Maintains | a month ago |
Abbvie IncABBV | 9 | Strong Buy | $196.00 | +31.30% | Maintains | a month ago |
Merck & Co IncMRK | 11 | Hold | $118.00 | +13.73% | Maintains | a month ago |
Bristol Myers Squibb CoBMY | 8 | Strong Sell | $50.00 | -0.62% | Maintains | a month ago |
Johnson & JohnsonJNJ | 14 | Hold | $171.00 | +10.74% | Maintains | 2 months ago |
Revance Therapeutics IncRVNC | 7 | Hold | $12.00 | +62.82% | Maintains | 2 months ago |
Organon & CoOGN | 7 | Hold | $22.00 | +99.64% | Maintains | 2 months ago |
Blueprint Medicines CorpBPMC | 4 | Strong Buy | $83.00 | +12.19% | Maintains | 4 months ago |
Nurix Therapeutics IncNRIX | 2 | Hold | $12.00 | +39.53% | Maintains | 5 months ago |
Eli Lilly & CoLLY | 13 | Strong Buy | $448.00 | -25.09% | Maintains | 8 months ago |
Bright Health Group IncBHG | 1 | Strong Buy | $2,880.00 | N/A | Initiates Coverage On | 2 years ago |
Biogen IncBIIB | 2 | Hold | $436.00 | N/A | Maintains | 2 years ago |
Translate Bio IncTBIO1 | 1 | Strong Buy | $19.00 | N/A | Initiates Coverage On | 3 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | $40.00 | N/A | Upgrades | 5 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Fibrogen IncFGEN | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Bioverativ IncBIVV | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.